Incyte (INCY) Financials: Revenue & Earnings

INCY$120.01—
BiotechnologyLarge CapHigh Quality
Compare
Market cap$23.36BEnterprise value—Revenue (TTM)$6.01BMarket positionTop 25%

Score

51
Neutral
Value
38
Quality
73
Growth
42

Financial Summary

Incyte Corporation (INCY) last printed $120.01. Equity value is $23.36B. Trailing earnings multiple 58.55. The revenue row is reported history.

Financials

2016201720182019202020212022202320242025
$1.11B$1.54B$1.88B$2.16B$2.67B$2.99B$3.39B$3.7B$4.24B$5.14B

Incyte (INCY) Financials: Revenue & Earnings

INCY price $120.01 —

Ticker
INCY
Price
$120.01
Change
—
Market cap
$23.36B
P/E
58.55
Forward P/E
14.85
Dividend yield
0.00%
Beta
0.78
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
38
Quality
73
Growth
42

Stocklytics score rationale: value 38, quality 73, growth 42.

AI Score 65. Incyte Corporation has a market cap of $24.47 billion and a high price-to-earnings ratio of 57.16, indicating potential overvaluation. Despite strong gross profit margins of 92.69% and a solid current ratio of 3.84, the company has reported negative net income in recent quarters, which raises concerns about its profitability and growth sustainability

Insights · Forecast · Financials · Learn

Stocklytics home · Screener